Skip to main content
Premium Trial:

Request an Annual Quote

Higher Software Sales Buoy Pharmacopeia s Q3 Revenues

NEW YORK, Nov 1 – A 27 percent increase in software sales helped to drive up Pharmacopeia’s third quarter revenues, which rose 12 percent to $27.1 million, compared with $24.3 million a year ago, the company said Wednesday.

" A strong performance by our software business was the result of strong sales growth in all geographic regions, including Asia,” Joseph Mollica, Pharmacopeia’s chairman, president, and CEO said in a statement. “We also benefited from the sale of new cheminformatics and bioinformatics products as a result of our acquisitions of Synopsys, Oxford Molecular, and Genetics Computer Group."

Pharmacopeia acquired Oxford Molecular, including its GCG bioinformatics software holding, earlier in the quarter.

For the quarter, the company posted net losses of $1.9 million, or eight cents a share, including acquisition-related charges, compared with net earnings of $500,000, or two cents a share, in the year ago period.

Excluding the charges, the company posted pro forma third quarter net income of $2.4 million, or 10 cents a share.

At the end of the quarter Pharmacopeia had cash, cash equivalents, and securities in excess of $166 million.

Based in Princeton, NJ, Pharmacopeia has about 700 employees.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.